Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial
| Status: | Completed |
|---|---|
| Conditions: | Colorectal Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/17/2018 |
| Start Date: | August 2014 |
| End Date: | June 20, 2017 |
Epidemiologic data consistently indicate that colorectal cancer survivors can improve their
quality-of-life and prognosis by engaging in physical activity. This study aims to build on
this epidemiologic work and translate the findings to inform and change patient behavior. The
specific aims are to: (1) Develop a mobile technology physical activity intervention among
colorectal cancer patients who have completed therapy. (2) Conduct a 3-month pilot randomized
controlled trial utilizing mobile technology to increase physical activity among 40 men and
women who have completed standard cytotoxic chemotherapy for primary stage I-III colorectal
cancer at the UCSF Helen Diller Family Comprehensive Cancer Center. Participants in the
intervention arm will receive a Fitbit® for self-monitoring, interactive text messages, and
educational print materials; participants in the control arm will receive educational print
materials at baseline and will be given a Fitbit® after completion of the 3-mo. follow-up
assessment.
quality-of-life and prognosis by engaging in physical activity. This study aims to build on
this epidemiologic work and translate the findings to inform and change patient behavior. The
specific aims are to: (1) Develop a mobile technology physical activity intervention among
colorectal cancer patients who have completed therapy. (2) Conduct a 3-month pilot randomized
controlled trial utilizing mobile technology to increase physical activity among 40 men and
women who have completed standard cytotoxic chemotherapy for primary stage I-III colorectal
cancer at the UCSF Helen Diller Family Comprehensive Cancer Center. Participants in the
intervention arm will receive a Fitbit® for self-monitoring, interactive text messages, and
educational print materials; participants in the control arm will receive educational print
materials at baseline and will be given a Fitbit® after completion of the 3-mo. follow-up
assessment.
Inclusion Criteria:
- stage I-III colon or rectal adenocarcinoma
- completed standard cytotoxic chemotherapy if medically indicated
- be considered disease-free at baseline
- be able to speak and read English
- have no contra-indication to moderate to vigorous aerobic exercise
- be able to walk unassisted
- be inactive at baseline (<150 min/week of moderate physical activity)
- have access to a mobile phone
- be able to navigate websites, fill out forms on the web, communicate by email, and
have regular access to the internet
We found this trial at
1
site
Click here to add this to my saved trials
